Cano, A.; Fonseca, E.; Ettcheto, M.; Sánchez-López, E.; de Rojas, I.; Alonso-Lana, S.; Morató, X.; Souto, E.B.; Toledo, M.; Boada, M.;
et al. Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals 2021, 14, 1057.
https://doi.org/10.3390/ph14101057
AMA Style
Cano A, Fonseca E, Ettcheto M, Sánchez-López E, de Rojas I, Alonso-Lana S, Morató X, Souto EB, Toledo M, Boada M,
et al. Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals. 2021; 14(10):1057.
https://doi.org/10.3390/ph14101057
Chicago/Turabian Style
Cano, Amanda, Elena Fonseca, Miren Ettcheto, Elena Sánchez-López, Itziar de Rojas, Silvia Alonso-Lana, Xavier Morató, Eliana B. Souto, Manuel Toledo, Mercè Boada,
and et al. 2021. "Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways" Pharmaceuticals 14, no. 10: 1057.
https://doi.org/10.3390/ph14101057
APA Style
Cano, A., Fonseca, E., Ettcheto, M., Sánchez-López, E., de Rojas, I., Alonso-Lana, S., Morató, X., Souto, E. B., Toledo, M., Boada, M., Marquié, M., & Ruíz, A.
(2021). Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals, 14(10), 1057.
https://doi.org/10.3390/ph14101057